As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

A global trial reveals tirzepatide helps people lose more weight faster than semaglutide. This breakthrough could change ...

Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.

The multi-dose, single-patient-use, prefilled pen allows for personalized treatment plans that can cater to individual patient needs "The availability of all doses of Mounjaro KwikPen represents a ...

The study was funded by Eli Lilly, the manufacturer of tirzepatide. Can a weekly injection lead to double-digit weight loss? In the fight against obesity, affecting over 650 million adults ...

Mounjaro ® KwikPen ® is a multi-dose single-patient-use prefilled pen. Each Mounjaro ® KwikPen ® contains four fixed doses of 0.6 mL, each dose taken once weekly. 2 It is available in six ...

Mounjaro ® KwikPen ® is a multi-dose single-patient-use prefilled pen. Each Mounjaro ® KwikPen ® contains four fixed doses of 0.6 mL, each dose taken once weekly. 2 It is available in six different ...

Zepbound — the brand name for tirzepatide — is the most effective GLP-1 medication for weight loss, according to one study.

The FDA declared that shortages of tirzepatide and semaglutide had ended ... platforms and offering single-dose vials instead of injector pens. “I have had direct conversations on behalf of ...

Over the past few years, a new class of injectable medications has changed the way obesity is treated. Two drugs—tirzepatide and semaglutide—have shown striking results in helping people lose weight ...